Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3059461 | Journal of Clinical Neuroscience | 2014 | 4 Pages |
Abstract
The use of thrombolytics delivered through an external ventricular drain has improved outcomes in intraventricular hemorrhage, a disease with a poor prognosis; however, presence of an arteriovenous malformation is generally considered a contraindication to thrombolytic use. Due do the high mortality with the current standard of care, thrombolytics should be considered as an acceptable treatment option despite the presence of an arteriovenous malformation in certain clinical situations. We review the available literature and present an additional patient to make the case for the use of thrombolytics for intraventricular hemorrhage from an arteriovenous malformation.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Kelley Keefe, Meysam Kebriaei, Andrew Gard, Arun-Angelo Patil,